##gff-version 3
##sequence-region Q14934 1 902
Q14934	UniProtKB	Chain	1	902	.	.	.	ID=PRO_0000205182;Note=Nuclear factor of activated T-cells%2C cytoplasmic 4	
Q14934	UniProtKB	Repeat	213	229	.	.	.	Note=SP 1	
Q14934	UniProtKB	Repeat	277	293	.	.	.	Note=SP 2%3B approximate	
Q14934	UniProtKB	Domain	401	582	.	.	.	Note=RHD;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00265	
Q14934	UniProtKB	Domain	586	683	.	.	.	Note=IPT/TIG	
Q14934	UniProtKB	DNA binding	430	437	.	.	.	.	
Q14934	UniProtKB	Region	114	119	.	.	.	Note=Calcineurin-binding	
Q14934	UniProtKB	Region	213	293	.	.	.	Note=2 approximate SP repeats	
Q14934	UniProtKB	Motif	268	270	.	.	.	Note=Nuclear localization signal	
Q14934	UniProtKB	Motif	672	674	.	.	.	Note=Nuclear localization signal	
Q14934	UniProtKB	Compositional bias	41	327	.	.	.	Note=Pro-rich	
Q14934	UniProtKB	Compositional bias	717	836	.	.	.	Note=Pro-rich	
Q14934	UniProtKB	Modified residue	168	168	.	.	.	Note=Phosphoserine%3B by MAPK7 and MAPK14;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11997522,ECO:0000269|PubMed:18347059;Dbxref=PMID:11997522,PMID:18347059	
Q14934	UniProtKB	Modified residue	170	170	.	.	.	Note=Phosphoserine%3B by MAPK7 and MAPK14;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11997522,ECO:0000269|PubMed:18347059;Dbxref=PMID:11997522,PMID:18347059	
Q14934	UniProtKB	Modified residue	213	213	.	.	.	Note=Phosphoserine%3B by MAPK8 and MAPK9;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17875713;Dbxref=PMID:17875713	
Q14934	UniProtKB	Modified residue	217	217	.	.	.	Note=Phosphoserine%3B by MAPK8 and MAPK9;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17875713;Dbxref=PMID:17875713	
Q14934	UniProtKB	Modified residue	289	289	.	.	.	Note=Phosphoserine%3B by RPS6KA3;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17213202;Dbxref=PMID:17213202	
Q14934	UniProtKB	Modified residue	344	344	.	.	.	Note=Phosphoserine%3B by RPS6KA3;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17213202;Dbxref=PMID:17213202	
Q14934	UniProtKB	Cross-link	689	689	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q14934	UniProtKB	Alternative sequence	1	712	.	.	.	ID=VSP_036697;Note=In isoform 22%2C isoform 23 and isoform 24. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:18675896;Dbxref=PMID:18675896	
Q14934	UniProtKB	Alternative sequence	1	465	.	.	.	ID=VSP_036698;Note=In isoform 19%2C isoform 20 and isoform 21. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:18675896;Dbxref=PMID:18675896	
Q14934	UniProtKB	Alternative sequence	1	70	.	.	.	ID=VSP_036699;Note=In isoform 12%2C isoform 13 and isoform 18. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:18675896;Dbxref=PMID:14702039,PMID:18675896	
Q14934	UniProtKB	Alternative sequence	1	32	.	.	.	ID=VSP_036700;Note=In isoform 9%2C isoform 10 and isoform 17. MGAASCEDEELEFKLVFGEEKEAPPLGAGGLG->MPASISSIFPGPTLLLSCGS;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:18675896;Dbxref=PMID:18675896	
Q14934	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_036701;Note=In isoform 2%2C isoform 3 and isoform 11. M->MITTLPSLLPASLASISHRVTNLPSNSLSHNPGLSKPDFPGNSSPGLPSSSSPGRDLGAPAGSM;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:18675896;Dbxref=PMID:18675896	
Q14934	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_036702;Note=In isoform 4%2C isoform 5 and isoform 14. M->MADGGADSAAQRLPEGPGRVAPGRDLGAPAGSM;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:18675896;Dbxref=PMID:18675896	
Q14934	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_036703;Note=In isoform 6%2C isoform 7 and isoform 15. M->MLSGRDLGAPAGSM;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:18675896;Dbxref=PMID:18675896	
Q14934	UniProtKB	Alternative sequence	773	880	.	.	.	ID=VSP_036704;Note=In isoform 11%2C isoform 14%2C isoform 15%2C isoform 16%2C isoform 17%2C isoform 18%2C isoform 21 and isoform 24. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:18675896;Dbxref=PMID:14702039,PMID:18675896	
Q14934	UniProtKB	Alternative sequence	881	902	.	.	.	ID=VSP_036705;Note=In isoform 3%2C isoform 5%2C isoform 7%2C isoform 8%2C isoform 10%2C isoform 13%2C isoform 20 and isoform 23. VSEIIGRDLSGFPAPPGEEPPA->GGCGTGGCECECVQEIALHVC;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:18675896;Dbxref=PMID:18675896	
Q14934	UniProtKB	Natural variant	160	160	.	.	.	ID=VAR_046985;Note=G->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:7749981;Dbxref=dbSNP:rs2229309,PMID:15489334,PMID:7749981	
Q14934	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_046986;Note=S->N;Dbxref=dbSNP:rs2228231	
Q14934	UniProtKB	Natural variant	800	800	.	.	.	ID=VAR_046987;Note=S->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:7749981;Dbxref=dbSNP:rs7149586,PMID:15489334,PMID:7749981	
Q14934	UniProtKB	Mutagenesis	168	168	.	.	.	Note=Promotes nuclear localization and increases transcriptional activity%3B when associated with A-170. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11997522;Dbxref=PMID:11997522	
Q14934	UniProtKB	Mutagenesis	170	170	.	.	.	Note=Promotes nuclear localization and increases transcriptional activity%3B when associated with A-168. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11997522;Dbxref=PMID:11997522	
Q14934	UniProtKB	Mutagenesis	213	213	.	.	.	Note=Marked decrease in phosphorylation by MAPK8 or MAPK9. Complete loss of phosphorylation by MAPK8 or MAPK9%2C but no effect on MAPK8/9-binding%3B when associated with A-217. Decreased transcriptional activity%3B when associated with A-217. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17875713;Dbxref=PMID:17875713	
Q14934	UniProtKB	Mutagenesis	217	217	.	.	.	Note=Marked decrease in phosphorylation by MAPK8 or MAPK9. Complete loss of phosphorylation by MAPK8 or MAPK9%2C but no effect on MAPK8/9-binding%3B when associated with A-213. Decreased transcriptional activity%3B when associated with A-213. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17875713;Dbxref=PMID:17875713	
Q14934	UniProtKB	Sequence conflict	359	359	.	.	.	Note=E->K;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q14934	UniProtKB	Sequence conflict	646	646	.	.	.	Note=L->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q14934	UniProtKB	Beta strand	587	594	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2YRP	
Q14934	UniProtKB	Beta strand	602	610	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2YRP	
Q14934	UniProtKB	Beta strand	616	620	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2YRP	
Q14934	UniProtKB	Turn	638	640	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2YRP	
Q14934	UniProtKB	Beta strand	645	649	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2YRP	
Q14934	UniProtKB	Beta strand	662	669	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2YRP	
Q14934	UniProtKB	Beta strand	671	673	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2YRP	
Q14934	UniProtKB	Beta strand	679	684	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2YRP	
Q14934	UniProtKB	Beta strand	687	689	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2YRP	
